Sampsa Hautaniemi Selected Research

Sampsa Hautaniemi Research Topics

Disease

41	Neoplasms (Cancer) 01/2022 - 01/2004
19	Breast Neoplasms (Breast Cancer) 02/2018 - 11/2002
14	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2015
8	Prostatic Neoplasms (Prostate Cancer) 03/2013 - 05/2004
6	Glioblastoma (Glioblastoma Multiforme) 06/2013 - 09/2010
5	Genomic Instability 08/2020 - 04/2009
4	Adenocarcinoma 01/2022 - 01/2013
3	Disease Progression 11/2021 - 01/2017
3	Melanoma (Melanoma, Malignant) 03/2021 - 12/2012
3	Carcinogenesis 11/2018 - 08/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 03/2011
3	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2012
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2011
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2017 - 04/2011
2	Hypersensitivity (Allergy) 05/2014 - 06/2010
2	Milk Hypersensitivity (Milk Allergy) 05/2014 - 06/2010
2	Glioma (Gliomas) 02/2013 - 01/2013
2	Lymphoma (Lymphomas) 05/2010 - 10/2006
2	Infections 11/2009 - 03/2005
1	Plague (Bubonic Plague) 01/2022
1	Ascites 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Ductal Carcinoma 02/2018
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2016
1	Triple Negative Breast Neoplasms 04/2015
1	Inflammation (Inflammations) 11/2014
1	Mycoses (Diseases, Fungus) 06/2014
1	Neuralgia (Stump Neuralgia) 06/2014
1	Wounds and Injuries (Trauma) 06/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2005
8	Pharmaceutical PreparationsIBA 11/2021 - 03/2011
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
6	MicroRNAs (MicroRNA)IBA 02/2018 - 01/2013
5	Messenger RNA (mRNA)IBA 02/2018 - 11/2002
5	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 11/2002
4	PlatinumIBA 01/2021 - 08/2015
4	Complementary DNA (cDNA)IBA 09/2004 - 11/2002
3	Drug CombinationsIBA 11/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 02/2018 - 01/2013
3	CathepsinsIBA 02/2018 - 03/2005
3	Calcibiotic Root Canal SealerIBA 01/2018 - 03/2011
3	Estrogen ReceptorsIBA 01/2016 - 01/2013
3	Small Interfering RNA (siRNA)IBA 02/2013 - 03/2005
3	Rituximab (Mabthera)FDA Link 04/2011 - 10/2006
2	NucleotidesIBA 08/2020 - 10/2019
2	Mitochondrial DNA (mtDNA)IBA 08/2020 - 10/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2019
2	taxaneIBA 12/2019 - 08/2015
2	Circulating Tumor DNAIBA 12/2019 - 01/2019
2	MucinsIBA 11/2018 - 01/2017
2	ZincIBA 02/2018 - 03/2012
2	Phenobarbital (Luminal)FDA Link 01/2017 - 04/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2016 - 03/2011
2	prostatic acid phosphataseIBA 02/2016 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 09/2011
2	ChromatinIBA 11/2015 - 09/2011
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2015 - 12/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2015 - 08/2011
2	Immunoglobulin E (IgE)IBA 05/2014 - 06/2010
2	EpitopesIBA 05/2014 - 06/2010
2	Immunoglobulin G (IgG)IBA 05/2014 - 06/2010
2	Genetic Markers (Genetic Marker)IBA 05/2013 - 01/2013
2	AndrogensIBA 03/2013 - 09/2011
2	ProteomeIBA 10/2011 - 03/2005
2	OligonucleotidesIBA 10/2006 - 06/2004
1	Therapeutic UsesIBA 11/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	niraparibIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Aurora KinasesIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2019
1	anagrelide (Agrylin)FDA LinkGeneric 01/2019
1	AntigensIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Guanosine Diphosphate Mannose (GDP Mannose)IBA 11/2018
1	Polysaccharides (Glycans)IBA 11/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 12/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2017
1	LipidsIBA 01/2016
1	Cell Adhesion MoleculesIBA 05/2015
1	CollagenIBA 05/2015
1	Membrane-Associated Matrix MetalloproteinasesIBA 05/2015
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 05/2015
1	CytokinesIBA 11/2014
1	Analgesics (Analgesic Drugs)IBA 06/2014
1	Adenosine (Adenocard)FDA LinkGeneric 06/2014
1	thiamine monophosphataseIBA 06/2014
1	Netrin-1IBA 06/2013

Therapy/Procedure

13	Therapeutics 11/2021 - 01/2004
8	Drug Therapy (Chemotherapy) 01/2022 - 10/2006
1	Neoadjuvant Therapy 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Adjuvant Chemotherapy 01/2017
1	Immunotherapy 05/2014
1	Castration 03/2013